A1cNow, the first handheld monitor for testing glycosylated hemoglobin (HbA1c)

There's lots of excitement about A1cNow, the first handheld monitor for testing glycosylated hemoglobin (HbA1c).

Experts put a lot of emphasis on monitoring glycosylated hemoglobin. Using HbA1c to get a 2 to 3 month picture of glycemic control helps determine appropriate therapy.

The Amer Diabetes Assoc recommends shooting for an HbA1c < 7%.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote